Biosyent's market cap is currently C$128.53M. The company's EPS TTM is C$0.18; its P/E ratio is 15.40; and it has a dividend yield of 1.76%. Biosyent is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
